HAP Trading’s Aerie Pharmaceuticals AERI Stock Holding History

HAP Trading’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-51,100	Closed	-$18K	–	1245
2017 Q4	$18K	Sell	51,100 -9,600	-16%	-$582K	﹤0.01%	810
2017 Q3	$65K	Buy	+60,700	New	+$3.31M	﹤0.01%	628

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's AERI Position: Q4 2017 in Review

HAP Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2017, closing a stake of 14,880 shares — an estimated $902K sold.

HAP Trading first reported a position in AERI in Q2 2015 and held it in 4 quarters. The position peaked at $931K in Q2 2015. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

HAP Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
HAP Trading sold 14,880 Aerie Pharmaceuticals shares in Q4 2017, an estimated $902K.
HAP Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 4 quarters.
HAP Trading's Aerie Pharmaceuticals position peaked at $931K in Q2 2015.
179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on HAP Trading's 13F filing for Q4 2017, filed 9 Feb 2018.